Veterinary Anesthetic Alfaxan Approved for U.S. Distribution

Alfaxan (alfaxalone 10 mg/mL) is approved for use in cats and dogs.


Published:

Each milliliter of Alfaxan contains 10 milligrams of the active ingredient alfaxalone.

An intravenous injectable anesthetic commonly used in Australia will be released to U.S. veterinarians Aug. 25, the manufacturer, Jurox Animal Health, reported.

Alfaxan (alfaxalone 10 mg/mL) is approved for use in cats and dogs. The drug is indicated for the induction and maintenance of anesthesia and for the induction of anesthesia followed by maintenance with an inhalant anesthetic.

Winning U.S. Food and Drug Administration approval of Alfaxan took time, said JJ O’Brien, CEO of Australia-based Jurox.

“Since beginning this process, we have had countless inquiries as to why it has not been available to U.S. veterinarians,” O’Brien said.

The drug is widely accepted by Australian veterinarians and has been used in 20 countries.

“An independent study commissioned by Jurox reported Australian veterinarians to rely on Alfaxan for induction as often as 74 percent of the time in cats and 52 percent in dogs,” the company stated.

Alfaxan’s U.S. distributors will include Henry Schein Animal Health, MWI Veterinary Supply, Patterson Veterinary Supply, NEVSCo, Midwest Veterinary Supply and Victor Medical Co.

Jurox earlier this summer opened its U.S. headquarters in Kansas City, Mo.

Archive »Read More

Henry Schein Adds Abaxis Veterinary Line

Henry Schein Animal Health and Patterson Veterinary Supply will distribute Abaxis products as a major competitor moves to direct sales.

Study: Mountain Lions in Southern California Lack Genetic Diversity

The study, led by the University of California, Davis, in partnership with The Nature Conservancy, raises concerns about the status of mountain lions in the Santa Ana and Santa Monica mountains.

Texas Now Free of VS, But Not Colorado

For the first time since May, Texas has no active cases of vesicular stomatitis, but Colorado authorities are still dealing with the disease.

Add your comment:

Events


Show More...